Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 121915-83-1
2. Rph56vwa1a
3. Sq 33,248
4. Sq-33248
5. Calteridol Calcium (usan)
6. Calteridol Calcium [usan]
7. Tricalcium;2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate
8. Unii-rph56vwa1a
9. Calteridol Calcium [usan:ban]
10. Calteridol Calcium [ii]
11. Chembl2106555
12. Calteridol Calcium [vandf]
13. Calteridol Calcium [who-dd]
14. (+-)-calcium Bis((10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))calciate(1-))
15. D03320
16. Q27288232
17. (+/-)-calcium Bis((10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))calciate(1-))
18. Calciate(1-), (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-n(sup 1),n(sup 4),n(sup 7),n(sup 10),o(sup 1),o(sup 4),o(sup 7),o(sup 10))-, Calcium (2:1)
19. Calciate(1-), (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-n(sup 1),n(sup 4,n(sup 7),n(sup 10),o(sup 1),o(sup 4),o(sup 7),o(sup 10))-, Calcium (2:1)
Molecular Weight | 923.1 g/mol |
---|---|
Molecular Formula | C34H58Ca3N8O14 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 22 |
Rotatable Bond Count | 10 |
Exact Mass | 922.2950211 g/mol |
Monoisotopic Mass | 922.2950211 g/mol |
Topological Polar Surface Area | 307 Ų |
Heavy Atom Count | 59 |
Formal Charge | 0 |
Complexity | 471 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
Market Place
Reply
13 Jun 2022
ABOUT THIS PAGE
A Calteridol Calcium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calteridol Calcium, including repackagers and relabelers. The FDA regulates Calteridol Calcium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calteridol Calcium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calteridol Calcium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Calteridol Calcium supplier is an individual or a company that provides Calteridol Calcium active pharmaceutical ingredient (API) or Calteridol Calcium finished formulations upon request. The Calteridol Calcium suppliers may include Calteridol Calcium API manufacturers, exporters, distributors and traders.
click here to find a list of Calteridol Calcium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Calteridol Calcium DMF (Drug Master File) is a document detailing the whole manufacturing process of Calteridol Calcium active pharmaceutical ingredient (API) in detail. Different forms of Calteridol Calcium DMFs exist exist since differing nations have different regulations, such as Calteridol Calcium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Calteridol Calcium DMF submitted to regulatory agencies in the US is known as a USDMF. Calteridol Calcium USDMF includes data on Calteridol Calcium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Calteridol Calcium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Calteridol Calcium suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Calteridol Calcium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Calteridol Calcium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Calteridol Calcium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Calteridol Calcium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Calteridol Calcium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Calteridol Calcium suppliers with NDC on PharmaCompass.
Calteridol Calcium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calteridol Calcium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calteridol Calcium GMP manufacturer or Calteridol Calcium GMP API supplier for your needs.
A Calteridol Calcium CoA (Certificate of Analysis) is a formal document that attests to Calteridol Calcium's compliance with Calteridol Calcium specifications and serves as a tool for batch-level quality control.
Calteridol Calcium CoA mostly includes findings from lab analyses of a specific batch. For each Calteridol Calcium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calteridol Calcium may be tested according to a variety of international standards, such as European Pharmacopoeia (Calteridol Calcium EP), Calteridol Calcium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calteridol Calcium USP).
LOOKING FOR A SUPPLIER?